EUVIMEDEUVIMED entdecken
Vergleichsstudie

Conformational flexibility governs phosphate-induced solubility enhancement: a comparative study of cimetidine and famotidine by pH-dependent dissolution, NMR titration, DOSY, and DFT analysis

Chihiro Tsunoda, Satoru Goto, Ryosuke Hiroshige, Kanji Hasegawa, Takahiro Kasai, Hikaru Kataoka, Tomohiro Tsuchida, Hiroshi Terada

European Journal of Pharmaceutics and Biopharmaceutics · 2026

DOI: 10.1016/j.ejpb.2026.115235 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Chihiro Tsunoda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika, Tokyo 125-8585, Japan. Hauptthemen laut MEDLINE: Cimetidine, Famotidine, Phosphates, Histamine H2 Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inorganic phosphate buffers are widely used in pharmaceutical dissolution testing, yet the direction of their effect on drug solubility is not uniform across solutes: for some basic drugs, phosphate decreases apparent solubility through insoluble salt formation or ionic-strength effects, while for others, our prior work has documented concentration-dependent solubility changes inconsistent with either mechanism. We report here that phosphate selectively increases the apparent cationic solubility of cimetidine (CIM) up to 2.6-fold but has a negligible effect on famotidine (FAM), two structurally distinct H2-receptor antagonists, across a range of pH values and buffer compositions. This solubility-enhancing effect is mechanistically distinct from the well-documented solubility-decreasing effects of phosphate reported for other basic drugs via insoluble salt formation or ionic-strength suppression; those mechanisms predict a concentration-dependent decrease in solubility, which is thermodynamically incompatible with the concentration-dependent increase observed here for CIM. The differential response between CIM and FAM cannot be explained by classical Henderson-Hasselbalch ionization models or by differences in pH or buffering capacity. Three independent experimental approaches converge on a consistent interpretation. pH-dependent solubility measurements showed that phosphate selectively increases the cationic solubility (Si) of CIM while leaving the neutral-form solubility (S0) unchanged; FAM showed no significant Si response. 1H NMR titration revealed progressive downfield shifts of CIM imidazole resonances (∼1.0 ppm over 10-100 mM phosphate) with vicinal coupling constants consistent with a shift toward the cis/gauche (Zusammen) conformation; FAM and histamine responded minimally (∼0.5-0.6 ppm). DOSY diffusion measurements showed that phosphate decreases CIM diffusion disproportionately relative to bulk viscosity, indicating stronger solute-solvent coupling for the conformationally flexible molecule. DFT-based Boltzmann analysis revealed that CIM possesses a broad low-energy conformer ensemble (partition function Z = 2.62), whereas FAM is dominated by a single rigid geometry (Z = 1.10). The correlation between conformational entropy and phosphate-induced solubility enhancement suggests that molecular flexibility is a key determinant of ion-specific buffer effects, with implications for BCS solubility classification using phosphate-buffered media.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CimetidineFamotidinePhosphatesHistamine H2 AntagonistsSolubilityHydrogen-Ion ConcentrationMagnetic Resonance SpectroscopyBuffersDensity Functional TheoryOsmolar ConcentrationBulk DrugsMolecular Conformation

Stichwörter der Autor:innen

Aqueous solubility enhancementConformational entropyConformational population analysisDOSY NMRKosmotropic ionsMolecular flexibilityPhosphate–solute interactions

Substanzen

CimetidineFamotidinePhosphatesBuffersHistamine H2 AntagonistsBulk Drugs

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika, Tokyo 125-8585, Japan.
  • Faculty of Pharmaceutical Sciences, Tokyo University of Science, 6-3-1 Niijuku, Katsushika, Tokyo 125-8585, Japan; Research Institute for Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 2…

Zitieren

APA

Tsunoda, C., Goto, S., Hiroshige, R., Hasegawa, K., Kasai, T., Kataoka, H., Tsuchida, T., & Terada, H. (2026). Conformational flexibility governs phosphate-induced solubility enhancement: a comparative study of cimetidine and famotidine by pH-dependent dissolution, NMR titration, DOSY, and DFT analysis. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115235

Vancouver

Tsunoda C, Goto S, Hiroshige R, Hasegawa K, Kasai T, Kataoka H, et al. Conformational flexibility governs phosphate-induced solubility enhancement: a comparative study of cimetidine and famotidine by pH-dependent dissolution, NMR titration, DOSY, and DFT analysis. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115235

BibTeX
@article{Tsunoda2026,
  author = {Tsunoda, Chihiro and Goto, Satoru and Hiroshige, Ryosuke and Hasegawa, Kanji and Kasai, Takahiro and Kataoka, Hikaru and Tsuchida, Tomohiro and Terada, Hiroshi},
  title = {Conformational flexibility governs phosphate-induced solubility enhancement: a comparative study of cimetidine and famotidine by pH-dependent dissolution, NMR titration, DOSY, and DFT analysis},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  doi = {10.1016/j.ejpb.2026.115235}
}
Kostenlos starten →